No Detectable Hypoxia in Malignant Salivary Gland Tumors: Preliminary Results

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 5, 2009, Pages 1319-1325

  Wijffels, Karien I E M ^a   Hoogsteen, Ilse J ^b   Lok, Jasper ^b   Rijken, Paulus F J W ^b   Marres, Henri A M ^b   de Wilde, Peter C M ^b   van der Kogel, Albert J ^b   Kaanders, Johannes H A M ^b  

^a DEVENTER HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Epidermal growth factor receptor; Hypoxia; Proliferation; Salivary gland tumors

Indexed keywords

BIOACTIVITY; BLOOD VESSELS; GLUCOSE; IMAGE ANALYSIS; ONCOLOGY; OXYGENATION; PEPTIDES; QUALITY CONTROL;

CARBONIC ANHYDRASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE TRANSPORTERS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1; MALIGNANT PROGRESSIONS; MALIGNANT SALIVARY GLANDS; MEDIAN VALUES; PROLIFERATION; QUANTITATIVE ANALYSIS; SALIVARY GLAND TUMORS; SOLID TUMORS; SURGICAL RESECTIONS; TISSUE SAMPLES; TISSUE SECTIONS;

TUMORS;

CARBONATE DEHYDRATASE IX; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IDOXURIDINE; PIMONIDAZOLE;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BLOOD VESSEL; BLOOD VESSEL DIAMETER; CANCER SURGERY; CANCER TISSUE; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SALIVARY GLAND; SALIVARY GLAND TUMOR; TISSUE SECTION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CELL HYPOXIA; CELL PROLIFERATION; DEOXYURIDINE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 2; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; NITROIMIDAZOLES; SALIVARY GLAND NEOPLASMS;

EID: 62649137079     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.06.1927     Document Type: Article

References (35)

1. Harris A.L. Hypoxia-A key regulatory factor in tumour growth. Nat Rev Cancer 2 (2002) 38-47
2. Le Q.T., Denko N.C., and Giaccia A.J. Hypoxic gene expression and metastasis. Cancer Metastasis Rev 23 (2004) 293-310
3. Graeber T.G., Osmanian C., Jacks T., et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379 (1996) 88-91
4. Hoogsteen I.J., Marres H.A., van der Kogel A.J., et al. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Clin Oncol (R Coll Radiol) 19 (2007) 385-396
5. Vaupel P., Mayer A., and Hockel M. Tumor hypoxia and malignant progression. Methods Enzymol 381 (2004) 335-354
6. Vaupel P., and Mayer A. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev 26 (2007) 225-239
7. Kaanders J.H., Bussink J., and van der Kogel A.J. Clinical studies of hypoxia modification in radiotherapy. Semin Radiat Oncol 14 (2004) 233-240
8. Schlingemann R.O., Dingjan G.M., Emeis J.J., et al. Monoclonal antibody PAL-E specific for endothelium. Lab Invest 52 (1985) 71-76
9. Rijken P.F., Bernsen H.J., and van der Kogel A.J. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc Res 50 (1995) 141-153
10. Jakobsson P.A., and Eneroth C.M. Variations in radiosensitivity of various types of malignant salivary-gland tumour. Acta Otolaryngol Suppl 263 (1969) 186-188
11. Hara S., Nakashiro K., Klosek S.K., et al. Hypoxia enhances c-Met/HGF receptor expression and signaling by activating HIF-1alpha in human salivary gland cancer cells. Oral Oncol 42 (2006) 593-598
12. Lindsley K.L., Cho P., Stelzer K.J., et al. Clinical trials of neutron radiotherapy in the United States. Bull Cancer Radiother 83 Suppl. (1996) 78s-86s
13. Wambersie A., Hendry J., Gueulette J., et al. Radiobiological rationale and patient selection for high-LET radiation in cancer therapy. Radiother Oncol 73 Suppl. 2 (2004) S1-S14
14. Kleiter M.M., Thrall D.E., Malarkey D.E., et al. A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. Int J Radiat Oncol Biol Phys 64 (2006) 592-602
15. Kaanders J.H., Wijffels K.I., Marres H.A., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62 (2002) 7066-7074
16. Hoskin P.J., Sibtain A., Daley F.M., et al. The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiother Oncol 72 (2004) 159-168
17. Arcasoy M.O., Amin K., Karayal A.F., et al. Functional significance of erythropoietin receptor expression in breast cancer. Lab Invest 82 (2002) 911-918
18. Rijken P.F., Peters J.P., and Van der Kogel A.J. Quantitative analysis of varying profiles of hypoxia in relation to functional vessels in different human glioma xenograft lines. Radiat Res 157 (2002) 626-632
19. Yuan H., Schroeder T., Bowsher J.E., et al. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med 47 (2006) 989-998
20. Lal A., Peters H., St Croix B., et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93 (2001) 1337-1343
21. Zhang J.Z., Behrooz A., and Ismail-Beigi F. Regulation of glucose transport by hypoxia. Am J Kidney Dis 34 (1999) 189-202
22. Sly W.S., and Hu P.Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 64 (1995) 375-401
23. Ishibashi H., Shiratuchi T., Nakagawa K., et al. Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol 37 (2001) 77-83
24. Wijffels K.I., Marres H.A., Peters J.P., et al. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas. Oral Oncol 44 (2008) 335-344
25. Hoogsteen I.J., Marres H.A., Wijffels K.I., et al. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. Clin Cancer Res 11 (2005) 97-106
26. Raleigh J.A., Zeman E.M., Calkins D.P., et al. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors. Acta Oncol 34 (1995) 345-349
27. Wykoff C.C., Beasley N.J., Watson P.H., et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60 (2000) 7075-7083
28. Ang K.K., Berkey B.A., Tu X., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62 (2002) 7350-7356
29. Vered M., Braunstein E., and Buchner A. Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck 24 (2002) 632-636
30. Agulnik M., Cohen E.W., Cohen R.B., et al. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol 25 (2007) 3978-3984
31. Psyrri A., Yu Z., Weinberger P.M., et al. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin Cancer Res 11 (2005) 5856-5862
32. Lo H.W., Xia W., Wei Y., et al. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res 65 (2005) 338-348
33. Lin S.Y., Makino K., Xia W., et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3 (2001) 802-808
34. Wang S.C., Nakajima Y., Yu Y.L., et al. Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol 8 (2006) 1359-1368
35. Dittmann K., Mayer C., Kehlbach R., et al. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport. Radiother Oncol 86 (2008) 375-382